These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35428263)

  • 21. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
    Phipps WS; SoRelle JA; Li QZ; Mahimainathan L; Araj E; Markantonis J; Lacelle C; Balani J; Parikh H; Solow EB; Karp DR; Sarode R; Muthukumar A
    Am J Clin Pathol; 2020 Sep; 154(4):459-465. PubMed ID: 32666092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19.
    Thiriard A; Meyer B; Eberhardt CS; Loevy N; Grazioli S; Adouan W; Fontannaz P; Marechal F; L'Huillier AG; Siegrist CA; Georges D; Putignano A; Marchant A; Didierlaurent AM; Blanchard-Rohner G
    Front Immunol; 2023; 14():1107156. PubMed ID: 37006315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays.
    Yun S; Ryu JH; Jang JH; Bae H; Yoo SH; Choi AR; Jo SJ; Lim J; Lee J; Ryu H; Cho SY; Lee DG; Lee J; Kim SC; Park YJ; Lee H; Oh EJ
    Ann Lab Med; 2021 Nov; 41(6):577-587. PubMed ID: 34108285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons.
    Savvateeva E; Filippova M; Valuev-Elliston V; Nuralieva N; Yukina M; Troshina E; Baklaushev V; Ivanov A; Gryadunov D
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
    Lynch KL; Whitman JD; Lacanienta NP; Beckerdite EW; Kastner SA; Shy BR; Goldgof GM; Levine AG; Bapat SP; Stramer SL; Esensten JH; Hightower AW; Bern C; Wu AHB
    Clin Infect Dis; 2021 Jan; 72(2):301-308. PubMed ID: 33501951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of dried blood spot sampling for detecting SARS-CoV-2 antibodies and total immunoglobulins in a large cohort of asymptomatic young adults.
    Ferentinos P; Snape D; Koivula F; Faustini S; Nicholson-Little A; Stacey M; Gifford R; Parsons I; Lamb L; Greeves J; O'Hara J; Cunningham AF; Woods D; Richter A; O'Shea MK
    J Immunol Methods; 2023 Jul; 518():113492. PubMed ID: 37201783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody responses to SARS-CoV-2 nucleocapsid and spike proteins in hospitalized patients with COVID-19: A multicenter, retrospective, cross-sectional study in Japan.
    Hibino M; Watanabe S; Tobe S; Maeda K; Horiuchi S; Nishiguchi S; Iwase A; Uryu K; Kobayashi S; Kondo T
    Respir Investig; 2022 Mar; 60(2):256-263. PubMed ID: 34924308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long-term dynamics of serum antibodies against SARS-CoV-2.
    de Sousa GF; Nogueira TDS; de Sales LS; Ferreira Maissner F; Araújo de Oliveira O; Rangel HL; Dos Santos DDG; Nunes-da-Fonseca R; de Souza-Menezes J; Nepomuceno-Silva JL; Mury FB; de Souza Gestinari R; Tanuri A; Ferreira ODC; Monteiro-de-Barros C
    PeerJ; 2022; 10():e14547. PubMed ID: 36540807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen-Specific Antibody Signature Is Associated with COVID-19 Outcome.
    Salgado BB; Jordão MF; de Morais TBDN; da Silva DSS; Pereira Filho IV; Salgado Sobrinho WB; Carvalho NO; Dos Santos RO; Forato J; Barbosa PP; Toledo-Teixeira DA; Pinto KR; Correia IS; Cordeiro IB; Souza Neto JN; Assunção EN; Val FFA; Melo GC; Sampaio VS; Monteiro WM; Granja F; Souza WM; Astolfi Filho S; Proenca-Modena JL; Lalwani JDB; Lacerda MVG; Nogueira PA; Lalwani P
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of COVID-19 Severity and Immunoglobulin Presence Against Spike and Nucleocapsid Proteins in SARS-CoV-2.
    Takamatsu A; Oshiro S; Mizutani N; Tada T; Tabe Y; Miida T; Kirikae T; Tagashira Y
    Viral Immunol; 2022 Apr; 35(3):254-258. PubMed ID: 35290756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients.
    Cheng L; Zhang X; Chen Y; Wang D; Zhang D; Yan S; Wang H; Xiao M; Liang T; Li H; Xu M; Hou X; Dai J; Wu X; Li M; Lu M; Wu D; Tian R; Zhao J; Zhang Y; Cao W; Wang J; Yan X; Zhou X; Liu Z; Xu Y; He F; Li Y; Yu X; Zhang S
    Signal Transduct Target Ther; 2021 Aug; 6(1):304. PubMed ID: 34404759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
    J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples.
    Szymczak A; Jędruchniewicz N; Torelli A; Kaczmarzyk-Radka A; Coluccio R; Kłak M; Konieczny A; Ferenc S; Witkiewicz W; Montomoli E; Miernikiewicz P; Bąchor R; Dąbrowska K
    J Gen Virol; 2021 Nov; 102(11):. PubMed ID: 34816794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2-specific antibody response characteristics in COVID-19 patients of different ages.
    Lu L; Yu S; Liu M; Li Y; Lei Q; Lin M; Lai D; Guo S; Jiang H; Hou H; Zheng Y; Wang X; Ma M; Zhang B; Chen H; Xue J; Zhang H; Qi H; Sun Z; Wang F; Fan X; Xu Z
    Acta Biochim Biophys Sin (Shanghai); 2022 Apr; 54(4):556-564. PubMed ID: 35607955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study.
    Parker E; Thomas J; Roper KJ; Ijaz S; Edwards T; Marchesin F; Katsanovskaja K; Lett L; Jones C; Hardwick HE; Davis C; Vink E; McDonald SE; Moore SC; Dicks S; Jegatheesan K; Cook NJ; Hope J; Cherepanov P; McClure MO; Baillie JK; Openshaw PJM; Turtle L; Ho A; Semple MG; Paxton WA; Tedder RS; Pollakis G;
    Front Immunol; 2023; 14():1146702. PubMed ID: 37056776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection.
    Haddad NS; Nguyen DC; Kuruvilla ME; Morrison-Porter A; Anam F; Cashman KS; Ramonell RP; Kyu S; Saini AS; Cabrera-Mora M; Derrico A; Alter D; Roback JD; Horwath M; O'Keefe JB; Wu HM; Ian Wong AK; Dretler AW; Gripaldo R; Lane AN; Wu H; Lee S; Hernandez M; Engineer V; Varghese J; Le S; Sanz I; Daiss JL; Eun-Hyung Lee F
    bioRxiv; 2020 Dec; ():. PubMed ID: 33299998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients.
    Ruetalo N; Businger R; Althaus K; Fink S; Ruoff F; Pogoda M; Iftner A; Ganzenmüller T; Hamprecht K; Flehmig B; Bakchoul T; Templin MF; Schindler M
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33627511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.